Form 8-K - Current report:
SEC Accession No. 0001193125-20-033440
Filing Date
2020-02-12
Accepted
2020-02-12 17:30:39
Documents
12
Period of Report
2020-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d884175d8k.htm   iXBRL 8-K 25308
  Complete submission text file 0001193125-20-033440.txt   132612

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA neog-20200206.xsd EX-101.SCH 3064
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20200206_lab.xml EX-101.LAB 15319
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20200206_pre.xml EX-101.PRE 9662
8 EXTRACTED XBRL INSTANCE DOCUMENT d884175d8k_htm.xml XML 2984
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 20605702
SIC: 2835 In Vitro & In Vivo Diagnostic Substances